Enhancement of T cell infiltration via tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumors-Reference-Cited by-同舟云学术

Enhancement of T cell infiltration via tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumors

Published:2023-05 Issue: Volume:23 Page:508-523
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Chen Tao,Xue Yucheng,Wang Shengdong,Lu Jinwei,Zhou Hao,Zhang Wenkan,Zhou Zhiyi,Li Binghao,Li Yong,Wang Zenan,Li Changwei,Eloy Yinwang,Sun Hangxiang,Shen Yihang^ORCID,Diarra Mohamed Diaty,Ge Chang,Chai Xupeng,Mou Haochen,Lin Peng,Yu Xiaohua^ORCID,Ye Zhaoming

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference48 articles.

1. Adoptive cell transfer as personalized immunotherapy for human cancer;Rosenberg;Science,2015

2. Engineered cellular immunotherapies in cancer and beyond;Finck;Nat. Med.,2022

3. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N. Engl. J. Med.,2017

4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

5. Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma;Kristensen;J. Clin. Invest.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens;Journal of Controlled Release;2024-09

2. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy;Journal of Controlled Release;2024-08

3. The potential and promise for clinical application of adoptive T cell therapy in cancer;Journal of Translational Medicine;2024-05-01

4. ZIF‐8‐Encapsulated Pexidartinib Delivery via Targeted Peptide‐Modified M1 Macrophages Attenuates MDSC‐Mediated Immunosuppression in Osteosarcoma;Small;2024-03-08

5. STING-driven activation of T cells: relevance for the adoptive cell therapy of cancer;Cell Stress;2023-11-14